XRAY vs AZTA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 29, 2026

XRAY

57.9
AI Score
VS
XRAY Wins

AZTA

34.7
AI Score

Investment Advisor Scores

XRAY

58score
Recommendation
HOLD

AZTA

35score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric XRAY AZTA Winner
Forward P/E 6.3291 29.0698 XRAY
PEG Ratio 0.633 0.5263 AZTA
Revenue Growth -4.1% 12.0% AZTA
Earnings Growth 15.2% 8777.8% AZTA
Tradestie Score 57.9/100 34.7/100 XRAY
Profit Margin -15.0% -20.0% XRAY
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY XRAY

Relative Price Performance (Last 90 Days)

XRAY 1M: -18.8% · 3M: -25.0% AZTA 1M: +9.2% · 3M: +33.4%

Current Technical Phase

XRAY

Markdown
Sell / avoid

Price below a falling SMA50 (slope -7.5%), weak momentum, RSI 28

RSI (14): 28.4 · Price: $8.74

AZTA

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (9.7% over 20 days), RSI 61

RSI (14): 60.9 · Price: $34.48

Fundamentals Snapshot

Metric XRAY AZTA
Market Cap — —
Forward P/E 5.8 58.7
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin 0.5% 0.4%
Operating Margin 0.1% 0.0%
EPS -2.69 -2.46
Dividend Yield 0.04% —

Frequently Asked Questions

Based on our detailed analysis, XRAY is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.